Detecting Mutations in Malaria Parasites and Chloroquine Resistance
Author Information
Author(s): Ojurongbe Olusola, Ogungbamigbe Titus O, Fagbenro-Beyioku Adetayo F, Fendel Rolf, Kremsner Peter G, Kun Jürgen FJ
Primary Institution: Department of Parasitology, Institute of Tropical Medicine, University of Tübingen
Hypothesis
Are allelic variations in pfcrt and pfmdr1 of P. falciparum isolates associated with chloroquine treatment outcomes?
Conclusion
The study found that the pfcrt T76 mutation is a reliable marker for chloroquine resistance, while the role of pfmdr1 mutations remains unclear.
Supporting Evidence
- 62% of the patients were cured with chloroquine treatment.
- 38% of the patients failed the treatment.
- The presence of pfcrt T76 mutation was significantly associated with treatment failure (P = 0.003).
- The study used a real-time PCR assay for rapid detection of mutations.
Takeaway
This study looked at how certain changes in malaria parasites can make them resistant to a common medicine called chloroquine. They found one specific change that is really important for understanding this resistance.
Methodology
The study used Fluorescence Resonance Energy Transfer (FRET) method on a real-time PCR instrument to test for mutations in malaria parasites.
Limitations
The study may not fully account for other factors influencing chloroquine resistance beyond the tested mutations.
Participant Demographics
116 children aged 1-12 years with acute uncomplicated P. falciparum malaria, including 59% males and 41% females.
Statistical Information
P-Value
0.003
Statistical Significance
p<0.05
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website